| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 10.719 | 23.210 | 25.741 | 33.723 | 38.414 |
| Total Income - EUR | - | - | - | - | - | 10.719 | 23.210 | 25.741 | 33.723 | 43.961 |
| Total Expenses - EUR | - | - | - | - | - | 73 | 1.804 | 6.613 | 13.811 | 26.070 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 10.646 | 21.406 | 19.128 | 19.913 | 17.891 |
| Net Profit/Loss - EUR | - | - | - | - | - | 10.339 | 20.710 | 18.356 | 16.509 | 13.662 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Sorvas Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 1.087 | 30.143 | 22.262 |
| Current Assets | - | - | - | - | - | 10.553 | 20.942 | 17.527 | 697 | 4.965 |
| Inventories | - | - | - | - | - | 0 | 0 | 241 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 12.572 | 0 | 0 |
| Cash | - | - | - | - | - | 10.553 | 20.942 | 4.713 | 697 | 4.965 |
| Shareholders Funds | - | - | - | - | - | 10.381 | 20.750 | 18.404 | 16.558 | 23.634 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 172 | 192 | 210 | 14.283 | 3.593 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sorvas Med S.r.l.